Epigenetic and functional changes imposed by NUP98-HOXA9 in a genetically engineered model of chronic myeloid leukemia progression

Documenti analoghi

• The Retinoblastoma Tumor Suppressor Is Required for the NUP98-HOXA9-Induced Aberrant Nuclear Envelope Phenotype
  di: Marcela Vaz, et al.
  Pubblicazione: (2021-10-01)
• NUP214 in Leukemia: It’s More than Transport
  di: Adélia Mendes, et al.
  Pubblicazione: (2019-01-01)
• Synergy of NUP98-HOXA10 Fusion Gene and NrasG12D Mutation Preserves the Stemness of Hematopoietic Stem Cells on Culture Condition
  di: Yong Dong, et al.
  Pubblicazione: (2019-08-01)
• NUP98 Rearrangements in AML: Molecular Mechanisms and Clinical Implications
  di: Sagarajit Mohanty
  Pubblicazione: (2023-07-01)
• Case report: NUP98::LEDGF fusion gene drives malignant hematological tumor with mixed immunological phenotype
  di: Song Xue, et al.
  Pubblicazione: (2024-09-01)